Inovio Pharmaceuticals, Inc. (INO) investor relations documents from the company's IR site: 4 presentations, 15 press releases; latest deck 2026-08-12. Read in-app with summaries. First-party data.
INOVIO Second Quarter 2026 Financial Results Conference Call: INOVIO's 2Q26 results show INO-3107 BLA on track for Oct 30 PDUFA, targeting RRP with significant surgery reduction potential.
INO overview · INO earnings · INO financials · INO KPIs · INO ownership · INO peers · INO filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.